| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
28,861 | 10,020 | 4,521 | 4,348 | 3,084 |
| Cost of Revenue
|
-11,230 | -3,694 | -1,552 | -1,656 | -1,150 |
|
Gross Profit
|
17,631 | 6,326 | 2,969 | 2,692 | 1,934 |
| Selling, General and Administrative Expenses
|
-58,010 | -46,437 | -27,177 | -20,645 | -17,941 |
|
Research and Development Expenses
|
-40,989 | -42,824 | -34,325 | -26,651 | -15,861 |
| Depreciation, Amortization and Depletion
|
-1,119 | -1,324 | -1,284 | -1,042 | -914 |
| Other Income/Expense, Operating
|
1,323 | 1,317 | 1,008 | 544 | 283 |
|
Operating Income/Expenses
|
-98,795 | -89,268 | -61,778 | -47,794 | -34,433 |
|
Total Operating Profit/Loss
|
-81,164 | -82,942 | -58,809 | -45,102 | -32,499 |
| Total Net Finance Income/Expense
|
-6,344 | -4,218 | 599 | 1,370 | -441 |
| Net Investment Income
|
-254 | -1,373 | 1,778 | -925 | 2,884 |
| Irregular Income/Expenses
|
-425 | -546 | 0 | 0 | -- |
|
Non-Operating Income/Expenses, Total
|
-7,023 | -6,137 | 2,377 | 445 | 2,443 |
|
Pretax Income
|
-88,183 | -89,076 | -56,432 | -44,657 | -30,056 |
|
Provision for Income Tax
|
-2,067 | -1,009 | -2,804 | 1,445 | -1,169 |
|
Net Income from Continuing Operations
|
-90,250 | -90,085 | -59,236 | -43,212 | -31,225 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-90,250 | -90,085 | -59,236 | -43,212 | -31,225 |
|
Net Income after Non-Controlling/Minority Interests
|
-90,250 | -90,085 | -59,236 | -43,212 | -31,225 |
|
Net Income Available to Common Stockholders
|
-90,250 | -90,085 | -59,236 | -43,212 | -31,225 |
|
Diluted Net Income Available to Common Stockholders
|
-90,250 | -90,085 | -59,236 | -43,212 | -31,225 |
| Basic EPS
|
-1.58 | -2.36 | -1.81 | -1.54 | -1.21 |
| Diluted EPS
|
-1.58 | -2.36 | -1.81 | -1.54 | -1.21 |
|
Basic Weighted Average Shares Outstanding
|
60,496.8900 | 38,108.4340 | 32,743.6050 | 27,968.1420 | 25,819.1650 |
|
Diluted Weighted Average Shares Outstanding
|
60,496.8900 | 38,108.4340 | 32,743.6050 | 27,968.1420 | 25,819.1650 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-84,466 | -89,062 | -58,048 | -47,011 | -30,191 |
|
EBITDA
|
-83,347 | -84,578 | -55,330 | -44,651 | -28,259 |
|
Normalized EBITDA
|
-81,346 | -76,545 | -53,140 | -41,115 | -28,445 |
|
Normalized Income
|
-88,749.2500 | -84,060.2500 | -57,593.5000 | -39,790.5664 | -31,364.5000 |
|
Total Unusual Items
|
2,001 | 8,033 | 2,190 | 3,536 | -186 |
12/31/2022 - 9/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade